Objective To investigate the clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension (PH),in order to provide more theory basis for clinical treatment.Methods A total of 80 PH patients was enrolled in this study.All the 80 cases were divided into conventional treatment group and sildenafil treatment group with 40 cases each.The 6-min walk test distance,Brog dyspnea score,pulmonary artery systolic pressure(SPAP),heart rate,circulation systolic blood pressure (cSBP),circulation diastolic blood pressure (cDBP),alanine aminotransferase (ALT),aspartate aminotransferase (AST),blood urea nitrogen (BUN) and serum creatinine (SCr) were recorded before and after treatment.The clinical efficacy was compared between two groups.Results The 6-min walk test distance,Brog dyspnea score and SPAP before treatment in conventional treatment group and sildenafil treatment group were (258.62 ±58.34),(260.22 ± 54.33) m; (3.2 ± 1.1),(3.3 ± 1.2) scores; (70.66 ± 6.52),(71.09 ± 6.61) mm Hg (1 mm Hg =0.133 kPa),and there was no significant difference between two groups (P ＞ 0.05).The 6-min walk test distance was (332.67 ± 63.51),(411.47 ± 75.86) m after treatment in conventional treatment group and sildenalil treatment group,which was increased compared with that before treatment (P ＜ 0.05).Brog dyspnea score and SPAP were (2.6 ± 0.8),(2.0 ± 0.6) scores and (61.43 ± 5.27),(47.84 ± 5.15) mm Hg after treatment in conventional treatment group and sildenafil treatment group,which were decreased compared with those before treatment (P ＜ 0.05).The improvement of the 6-min walk test distance,Brog dyspnea score and SPAP in sildenafil treatment group were better than those in conventional treatment group (P ＜0.05).There was no significant difference in the heart rate,cSBP,cDBP,ALT,AST,BUN,SCr before and after treatment in two groups (P ＞ 0.05).The total effective rate in sildenafil treatment group was higher than that in conventional treatment group [77.5％ (31/40) vs.57.5％ (23/40)],and there was significant difference (P ＜ 0.05).The side effects were main headache,blushing,dyspepsia.Conclusion Sildenafil has more effective clinical efficacy in treating PH patients with accepted side-effect,which is worthy to be popularized in the clinical application.

Objective To evaluate the effect and safety of thymosin combined with biapenem in the treatment of severe lower respiratory tract infection of gram negative bacilli.Methods 54 patients with severe lower respiratory tract infection of gram negative bacilli were randomly divided into study group (group A) and control group (group B),group A was treated with thymosin and biapenem,group B biapenem.All patients were treated for 7 ～ 14 days in a course.The clinical effect,treatment time of biapenem,the bacterial clearance rate and adverse drug reaction betweeen two groups were compared.Results The clinical effective rate of group A and B were 84.6％ and 82.1％,respectively,there was no statistical difference (P ＞ 0.05).Treatment time of biapenem in group A and B was (8.2 ±3.4) days and (13.2 ± 3.6) days,respectively,there was statistical difference (P ＜ 0.05).The bacterial clearance rate of group A and B were 86.7％ and 80.7％,respectively,there was no statistical difference between two groups (P ＞ 0.05).Conclusion The treatment time of thymosin combined with biapenem treatment of gram-negative bacilli severe respiratory tract infection was shorter than that of biapenem alone treatment,and it was safe,effective,and worthy of ciinical application.